Optimal Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$981K Hold
3,015
0.12% 239
2021
Q2
$941K Hold
3,015
0.11% 256
2021
Q1
$961K Sell
3,015
-4,000
-57% -$1.28M 0.12% 238
2020
Q4
$2.27M Hold
7,015
0.32% 102
2020
Q3
$1.94M Sell
7,015
-451
-6% -$130K 0.28% 124
2020
Q2
$1.8M Sell
7,466
-3,787
-34% -$760K 0.29% 125
2020
Q1
$1.63K Buy
11,253
+7,547
+204% +$1.25M 0.15% 219
2019
Q4
$632K Buy
+3,706
New +$687K 0.1% 293

Other funds holding ABMD

Optimal Asset Management's ABMD Position: Q3 2021 in Review

Optimal Asset Management held its Abiomed Inc (ABMD) position steady in Q3 2021 at 3,015 shares worth $981K. The position accounts for 0.12% of the portfolio, ranked #239.

Optimal Asset Management first reported a position in ABMD in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.27M in Q4 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Optimal Asset Management held 3,015 shares of Abiomed Inc worth $981K as of Q3 2021.
  • Optimal Asset Management left its Abiomed Inc share count unchanged in Q3 2021.
  • Abiomed Inc made up 0.12% of Optimal Asset Management's portfolio in Q3 2021, its #239 holding.
  • Optimal Asset Management first reported a position in Abiomed Inc in Q4 2019 and has held it in 8 quarters since.
  • Optimal Asset Management's Abiomed Inc position peaked at $2.27M in Q4 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.